MeCP2 interacts with chromosomal microRNAs in brain

Epigenetics. 2017;12(12):1028-1037. doi: 10.1080/15592294.2017.1391429.

Abstract

Although methyl CpG binding domain protein-2 (MeCP2) is commonly understood to function as a silencing factor at methylated DNA sequences, recent studies also show that MeCP2 can bind unmethylated sequences and coordinate gene activation. MeCP2 displays broad binding patterns throughout the genome, with high expression levels similar to histone H1 in neurons. Despite its significant presence in the brain, only subtle gene expression changes occur in the absence of MeCP2. This may reflect a more complex regulatory mechanism of MeCP2 to complement chromatin binding. Using an RNA immunoprecipitation of native chromatin technique, we identify MeCP2 interacting microRNAs in mouse primary cortical neurons. In addition, comparison with mRNA sequencing data from Mecp2-null mice suggests that differentially expressed genes may indeed be targeted by MeCP2-interacting microRNAs. These findings highlight the MeCP2 interaction with microRNAs that may modulate its binding with chromatin and regulate gene expression.

Keywords: MeCP2; RNA-chromatin immunoprecipitation; microRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / cytology
  • Brain / metabolism*
  • Cells, Cultured
  • Methyl-CpG-Binding Protein 2 / genetics
  • Methyl-CpG-Binding Protein 2 / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Neurons / metabolism
  • Protein Binding

Substances

  • Mecp2 protein, mouse
  • Methyl-CpG-Binding Protein 2
  • MicroRNAs

Grants and funding

This study was supported by a National Health and Medical Research Council (NHMRC) program grants (Numbers APP0526681, APP1113188). We acknowledge the fellowship support from the NHMRC. This work was supported in part by the Victorian Government's Operational Infrastructure Support Program.